Mogroside V stimulates osteoblast proliferation and differentiation by promoting LncRNA TUG1 expression

doi:10.3969/j.issn.2095-4344.2735

Abstract

Abstract:

BACKGROUND: Osteoporosis is a balance disorder between bone formation of osteoblasts and bone resorption of osteoclasts during bone remodeling. Strict control of bone remodeling at the cellular level is important to maintain bone homeostasis and avoid osteoporosis. Previous studies have shown that 1.25×10^-2 g/L mogroside V can promote osteoblast proliferation and differentiation, and its mechanism may be related to LncRNA TUG1.

OBJECTIVE: To investigate the role of LncRNA TUG1 in the promotion of osteoblast proliferation and differentiation by mogroside V.

METHODS: Osteoblasts from neonatal Sprague-Dawley rats were extracted by two-step enzymatic digestion. The cells were divided into two groups and treated with 0 and 1.25×10^-2 g/L Mogroside V. The LncRNA was detected after 2 days of culture. LncRNA TUG1 silencing virus was designed and synthetized. The newly extracted osteoblasts were divided into normal cell control group, mogroside V intervention group, mogroside V+negative virus group, TUG1 silent group, and mogroside V+TUG1 silent group. The proliferation of osteoblasts was observed by FDA fluorescence staining at 2, 4, and 6 days after processing according to the above grouping conditions. After 6 days of treatment on osteoblasts, the effect of TUG1 on osteoblast proliferation and differentiation was studied by alkaline phosphatase staining, alizarin red staining and qRT-PCR.

RESULTS AND CONCLUSION: LncRNA detection showed that 1.25×10^-2 g/L Mogroside V significantly promoted the expression of LncRNA TUG1 in osteoblasts. FDA fluorescent staining showed that silencing of TUG1 inhibited the positive effect of mogroside V on osteoblast proliferation. After 6 days of treatment, alkaline phosphatase staining and alizarin red staining showed that silencing of TUG1 inhibited the positive effect of mogroside V on mineralization of osteoblasts. The results of qRT-PCR showed that Runx2, BSP, OCN and COL1A1 genes were highly expressed in the mogroside V intervention group, but their expression was inhibited in the mogroside V+TUG1 silent group. Overall findings indicate that mogroside V stimulates the proliferation and differentiation of osteoblasts by promoting the expression of LncRNA TUG1.

Key words: mogroside V, LncRNA TUG1, osteoblasts, cell proliferation, cell differentiation, osteoporosis, Guangxi Natural Science Foundation

CLC Number:

Yao Shunhan, Wei Huacheng, Qin Jiagang, Liao Liang. Mogroside V stimulates osteoblast proliferation and differentiation by promoting LncRNA TUG1 expression[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(26): 4129-4134.

Figures/Tables 6

References

[1] RUSSOW G, JAHN D, APPELT J, et al. Anabolic Therapies in Osteoporosis and Bone Regeneration. International Int J Mol Sci. 2018;20(1). pii: E83.

[2] COSMAN F, DE BEUR SJ, LEBOFF MS, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis.Osteoporos Int. 2014; 25(10):2359-2381.

[3] TATANGELO G, WATTS J, LIM K, et al. The Cost of Osteoporosis, Osteopenia, and Associated Fractures in Australia in 2017.J Bone Miner Res. 2019;34(4):616-625.

[4] BURGE R, DAWSON-HUGHES B, SOLOMON DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.J Bone Miner Res. 2007;22(3):465-475.

[5] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中国全科医学,2017,20(32):3963-3982.

[6] TARANTINO U, IOLASCON G, CIANFEROTTI L, et al. Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology.J Orthop Traumatol. 2017;18(Suppl 1):3-36.

[7] ABDELGAWAD ME, DELAISSE JM, HINGE M, et al. Early reversal cells in adult human bone remodeling: osteoblastic nature, catabolic functions and interactions with osteoclasts.Histochem Cell Biol. 2016; 145(6):603-615.

[8] MARIE PJ. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.Eur J Endocrinol. 2011;165(1):1-10.

[9] HUNG T, CHANG HY. Long noncoding RNA in genome regulation. RNA Biol. 2010;7(5):582-585

[10] RICHARD BOLAND C. Non-coding RNA: It's Not Junk.Dig Dis Sci. 2017;62(5):1107-1109.

[11] TAKASAKI M, KONOSHIMA T, MURATA Y, et al. Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori. Cancer Lett. 2003;198(1):37-42.

[12] CHEN WJ, WANG J, QI XY, et al. The antioxidant activities of natural sweeteners, mogrosides, from fruits of Siraitia grosvenori. Int J Food Sci Nutr. 2007;58(7):548-556.

[13] LIU H, QI X, YU K, et al. AMPK activation is involved in hypoglycemic and hypolipidemic activities of mogroside-rich extract from Siraitia grosvenorii (Swingle) fruits on high-fat diet/streptozotocin-induced diabetic mice. Food Funct.2019;10(1):151-162.

[14] 姚顺晗,廖亮,覃家港,韦华成.罗汉果皂苷V刺激成骨细胞增殖与分化[J].中国组织工程研究,2019,23(29):4701-4706.

[15] REFAI NS, LOUKA ML, HALIM HY, et al. Long non-coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: Clinical significance. J Gene Med. 2019;21(9):e3112.

[16] SUN Z, HUANG G, CHENG H. Transcription factor induces the up-regulation of lncRNA to promote progression and adriamycin resistance in urothelial carcinoma of the bladder.Cancer Manag Res. 2019;11:6079-6090.

[17] ZHANG Z, XIONG R, LI C, et al. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2.Acta Biochim Biophys Sin (Shanghai). 2019;51(8):826-833.

[18] CHEN J, YU W, RUAN Z. TUG1/miR-421/PINK1: A potential mechanism for treating myocardial ischemia-reperfusion injury.Int J Cardiol. 2019;292:197.

[19] ZHOU H, WANG B, YANG YX, et al. Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature. Biomed Res Int. 2019;2019:7159592.

[20] LIU J, LIN J, LI Y, et al. Prognostic role of LncRNA TUG1 for cancer outcome: Evidence from 840 cancer patients.Oncotarget.2017; 8(30): 50051-50060.

[21] YANG L, YANG J, PAN T, et al. Liraglutide increases bone formation and inhibits bone resorption in rats with glucocorticoid-induced osteoporosis.J Endocrinol Invest. 2019;42(9):1125-1131.

[22] CHEN X, WANG Z, DUAN N, et al. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59(2):99-107.

[23] YANG G, LU X, YUAN L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097-1109.

[24] HUANG Y, ZHENG Y, JIA L, et al. Long Noncoding RNA H19 Promotes Osteoblast Differentiation Via TGF-β1/Smad3/HDAC Signaling Pathway by Deriving miR-675.Stem Cells. 2015;33(12):3481-3492.

[25] CHEN L, SONG Z, HUANG S, et al. lncRNA DANCR suppresses odontoblast-like differentiation of human dental pulp cells by inhibiting wnt/β-catenin pathway.Cell Tissue Res. 2016;364(2):309-318.

[26] KOROMILA T, BANIWAL SK, SONG YS, et al. Glucocorticoids antagonize RUNX2 during osteoblast differentiation in cultures of ST2 pluripotent mesenchymal cells. J Cell Biochem. 2014;115(1):27-33.

[27] FLORES MV, LAM EY, CROSIER P, et al. A hierarchy of Runx transcription factors modulate the onset of chondrogenesis in craniofacial endochondral bones in zebrafish.Dev Dyn. 2006;235(11): 3166-3176.

[28] 张弘,姚宇,孙佳栋,等.NELL-1调控RUNX2的P1启动子诱导成骨分化[J].中华口腔医学研究杂志(电子版),2017,11(4):197-203.

[29] QIN X, JIANG Q, MATSUO Y, et al. Cbfb regulates bone development by stabilizing Runx family proteins.J Bone Miner Res. 2015;30(4): 706-714.

[30] FOSTER BL, AO M, SALMON CR, et al. Osteopontin regulates dentin and alveolar bone development and mineralization. Bone. 2018;107: 196-207.

[31] HOSSEINI S, NADERI-MANESH H, VALI H, et al. Contribution of osteocalcin-mimetic peptide enhances osteogenic activity and extracellular matrix mineralization of human osteoblast-like cells. Colloids Surf B Biointerfaces. 2019;173:662-671.

[32] ZHANG W, CHEN J, TAO J, et al. The use of type 1 collagen scaffold containing stromal cell-derived factor-1 to create a matrix environment conducive to partial-thickness cartilage defects repair. Biomaterials. 2013;34(3):713-723.

[33] YOUNG TL, MATSUDA T, CEPKO CL. The noncoding RNA taurine upregulated gene 1 is required for differentiation of the murine retina. Curr Biol.2005;15(6):501-512.

[34] 熊乐,卢婍,刘安文.长链非编码RNA TUG1在恶性肿瘤中的研究进展[J].临床与实验病理学杂志,2017,33(4):425-428.

[35] KHALIL AM, GUTTMAN M, HUARTE M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression.Proc Natl Acad Sci U S A. 2009;106(28):11667-11672.

[36] LIU SC, SUN QZ, QIAO XF, et al. LncRNA TUG1 influences osteoblast proliferation and differentiation through the Wnt/β-catenin signaling pathway.Eur Rev Med Pharmacol Sci.2019;23(11):4584-4590.